429 related articles for article (PubMed ID: 28238460)
1. [Irritable bowel syndrome with constipation and functional constipation in adults: Treatment (Part 2 of 2)].
Mearin F; Ciriza C; Mínguez M; Rey E; Mascort JJ; Peña E; Cañones P; Júdez J;
Aten Primaria; 2017 Mar; 49(3):177-194. PubMed ID: 28238460
[TBL] [Abstract][Full Text] [Related]
2. [Irritable bowel syndrome with constipation and functional constipation in adults: Treatment (Part 2 of 2)].
Mearin F; Ciriza C; Mínguez M; Rey E; Mascort JJ; Peña E; Cañones P; Júdez J;
Semergen; 2017 Mar; 43(2):123-140. PubMed ID: 28189496
[TBL] [Abstract][Full Text] [Related]
3. [Clinical practice guidelines: Irritable bowel syndrome with constipation and functional constipation in adults: Concept, diagnosis, and healthcare continuity. (Part 1 of 2)].
Mearin F; Ciriza C; Mínguez M; Rey E; Mascort JJ; Peña E; Cañones P; Júdez J; ; ; ; ; ; ;
Aten Primaria; 2017 Jan; 49(1):42-55. PubMed ID: 28027792
[TBL] [Abstract][Full Text] [Related]
4. [Clinical practice guidelines: Irritable bowel syndrome with constipation and functional constipation in adults: Concept, diagnosis, and healthcare continuity. (Part 1 of 2)].
Mearin F; Ciriza C; Mínguez M; Rey E; Mascort JJ; Peña E; Cañones P; Júdez J;
Semergen; 2017; 43(1):43-56. PubMed ID: 27810257
[TBL] [Abstract][Full Text] [Related]
5. Clinical Practice Guideline: Irritable bowel syndrome with constipation and functional constipation in the adult.
Mearin F; Ciriza C; Mínguez M; Rey E; Mascort JJ; Peña E; Cañones P; Júdez J
Rev Esp Enferm Dig; 2016 Jun; 108(6):332-63. PubMed ID: 27230827
[TBL] [Abstract][Full Text] [Related]
6. Faecal retention: a common cause in functional bowel disorders, appendicitis and haemorrhoids--with medical and surgical therapy.
Raahave D
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748875
[TBL] [Abstract][Full Text] [Related]
7. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
[TBL] [Abstract][Full Text] [Related]
8. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
Gale JD
Adv Ther; 2009 May; 26(5):519-30. PubMed ID: 19444393
[TBL] [Abstract][Full Text] [Related]
9. [Motility and functional gastrointestinal disorders].
Mearin F; Rey E; Balboa A
Gastroenterol Hepatol; 2014 Sep; 37 Suppl 3():3-13. PubMed ID: 25294261
[TBL] [Abstract][Full Text] [Related]
10. Irritable bowel syndrome.
Sebastián Domingo JJ
Med Clin (Barc); 2022 Jan; 158(2):76-81. PubMed ID: 34238582
[TBL] [Abstract][Full Text] [Related]
11. Constipation: Pathophysiology and Current Therapeutic Approaches.
Sharma A; Rao S
Handb Exp Pharmacol; 2017; 239():59-74. PubMed ID: 28185025
[TBL] [Abstract][Full Text] [Related]
12. Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.
Thomas RH; Luthin DR
Pharmacotherapy; 2015 Jun; 35(6):613-30. PubMed ID: 26016701
[TBL] [Abstract][Full Text] [Related]
13. Functional and motor gastrointestinal disorders.
Mearin F; Rey E; Balboa A
Gastroenterol Hepatol; 2016 Sep; 39 Suppl 1():3-13. PubMed ID: 27888862
[TBL] [Abstract][Full Text] [Related]
14. [The new guideline on irritable bowel syndrome: what is new?].
von Schassen H; Andresen V; Layer P
Dtsch Med Wochenschr; 2021 Oct; 146(19):1243-1248. PubMed ID: 34553347
[TBL] [Abstract][Full Text] [Related]
15. Management of Chronic Abdominal Distension and Bloating.
Lacy BE; Cangemi D; Vazquez-Roque M
Clin Gastroenterol Hepatol; 2021 Feb; 19(2):219-231.e1. PubMed ID: 32246999
[TBL] [Abstract][Full Text] [Related]
16. A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain.
Mearin F; Caballero AM; Serra J; Brotons C; Tantiñà A; Fort E; Martínez-Cerezo FJ; Perelló A; Sánchez-Antolín G; Rey E; Angós Musgo R; Berdier R; Gómez-Rodríguez B; Clavé P; García-Alonso M; Torán-Monserrat P; Tack J
Gastroenterol Hepatol; 2019 Mar; 42(3):141-149. PubMed ID: 30612850
[TBL] [Abstract][Full Text] [Related]
17. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
[TBL] [Abstract][Full Text] [Related]
18. Chronic constipation in Rome IV era: The Indian perspective.
Ghoshal UC
Indian J Gastroenterol; 2017 May; 36(3):163-173. PubMed ID: 28643273
[TBL] [Abstract][Full Text] [Related]
19. Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment.
Paré P; Bridges R; Champion MC; Ganguli SC; Gray JR; Irvine EJ; Plourde V; Poitras P; Turnbull GK; Moayyedi P; Flook N; Collins SM
Can J Gastroenterol; 2007 Apr; 21 Suppl B(Suppl B):3B-22B. PubMed ID: 17464377
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in patients with different constipation subtypes based on the Rome III criteria.
Ruiz-López MC; Coss-Adame E
Rev Gastroenterol Mex; 2015; 80(1):13-20. PubMed ID: 25726441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
